Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedJan 30, 2025
DataAggregated Company Financials
Companies21
  • 7D3.6%
  • 3M-17.6%
  • 1Y-18.1%
  • YTD-3.7%

In the last week, the Healthcare industry is up 5.2%, with Novo Nordisk up 4.5%. Meanwhile, Genmab actually underperformed within the industry, shrinking 7.7% in the last week. In the past year, the industry is down 15%. Looking forward, earnings are forecast to grow by 14% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 30 Jan 2025DKK 3.3tDKK 387.4bDKK 111.3b28.9x29.2x8.4x
Sat, 28 Dec 2024DKK 3.4tDKK 387.4bDKK 111.3b29.9x30.1x8.7x
Mon, 25 Nov 2024DKK 3.9tDKK 387.4bDKK 111.3b31x34.9x10x
Wed, 23 Oct 2024DKK 4.1tDKK 372.2bDKK 107.2b35.4x38.6x11.1x
Fri, 20 Sep 2024DKK 4.6tDKK 371.9bDKK 107.1b36.7x42.9x12.4x
Sun, 18 Aug 2024DKK 4.7tDKK 370.7bDKK 107.0b37.2x43.9x12.7x
Tue, 16 Jul 2024DKK 4.9tDKK 355.2bDKK 106.2b35.5x46.2x13.8x
Thu, 13 Jun 2024DKK 4.9tDKK 355.3bDKK 106.2b36.4x46.3x13.9x
Sat, 11 May 2024DKK 4.5tDKK 354.9bDKK 106.0b34.6x42.5x12.7x
Mon, 08 Apr 2024DKK 4.5tDKK 341.2bDKK 99.6b37.4x44.7x13x
Wed, 06 Mar 2024DKK 4.4tDKK 340.0bDKK 98.9b38.2x44.6x13x
Fri, 02 Feb 2024DKK 4.0tDKK 320.8bDKK 90.1b32x44.7x12.6x
Sun, 31 Dec 2023DKK 3.6tDKK 320.4bDKK 90.0b32.8x40.4x11.3x
Tue, 28 Nov 2023DKK 3.7tDKK 320.5bDKK 90.0b33.2x40.9x11.5x
Thu, 26 Oct 2023DKK 3.6tDKK 305.6bDKK 82.3b26.6x43.4x11.7x
Sat, 23 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b33.8x41.3x11.1x
Mon, 21 Aug 2023DKK 3.3tDKK 303.2bDKK 81.2b36.8x40.8x10.9x
Wed, 19 Jul 2023DKK 2.9tDKK 286.9bDKK 75.4b39x38.7x10.2x
Fri, 16 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40.5x40.2x10.6x
Sun, 14 May 2023DKK 3.2tDKK 284.8bDKK 74.9b41.2x43.1x11.3x
Tue, 11 Apr 2023DKK 3.0tDKK 272.4bDKK 68.5b39.4x43.5x10.9x
Thu, 09 Mar 2023DKK 2.8tDKK 292.6bDKK 69.2b38.7x40.1x9.5x
Sat, 04 Feb 2023DKK 2.7tDKK 285.8bDKK 69.0b38.1x38.9x9.4x
Mon, 02 Jan 2023DKK 2.7tDKK 276.0bDKK 66.3b36.7x40.3x9.7x
Wed, 30 Nov 2022DKK 2.6tDKK 276.2bDKK 66.3b37.6x38.8x9.3x
Fri, 28 Oct 2022DKK 2.4tDKK 261.2bDKK 62.4b37.3x37.9x9.1x
Sun, 25 Sep 2022DKK 2.2tDKK 261.4bDKK 62.4b33.6x35.1x8.4x
Tue, 23 Aug 2022DKK 2.4tDKK 260.1bDKK 62.5b36x38.4x9.2x
Thu, 21 Jul 2022DKK 2.5tDKK 247.8bDKK 59.9b36.7x41x9.9x
Sat, 18 Jun 2022DKK 2.2tDKK 247.7bDKK 59.9b33.8x36.6x8.9x
Mon, 16 May 2022DKK 2.2tDKK 247.9bDKK 59.8b34.5x37.3x9x
Wed, 13 Apr 2022DKK 2.4tDKK 238.0bDKK 59.8b38.5x40.9x10.3x
Fri, 11 Mar 2022DKK 2.2tDKK 238.0bDKK 59.7b36.1x36.3x9.1x
Sun, 06 Feb 2022DKK 2.1tDKK 235.9bDKK 59.5b40.6x35.1x8.9x
Price to Earnings Ratio

35.1x


Total Market Cap: DKK 2.1tTotal Earnings: DKK 59.5bTotal Revenue: DKK 235.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 40.2x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 29.9x which is lower than its 3-year average PE of 40.2x.
  • The 3-year average PS ratio of 10.7x is higher than the industry's current PS ratio of 8.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 23% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market2.40%
Healthcare3.59%
Pharma4.43%
Life Sciences3.64%
Healthtech1.48%
Medical Equipment0.86%
Healthcare Services-4.32%
Biotech-4.98%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 97.5x.
    • Analysts are expecting annual earnings growth of 17.5%, which is higher than its past year's earnings decline of 23.7% per year.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 20.9x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 38% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 607.704.5%
+DKK 115.6b		-21.6%PE28.5x
COLO B ColoplastDKK 831.801.4%
+DKK 2.6b		4.3%PE37.1x
HLUN B H. LundbeckDKK 42.825.7%
+DKK 2.3b		22.6%PE15.8x
GUBRA GubraDKK 672.008.4%
+DKK 848.0m		448.6%PS49x
AMBU B AmbuDKK 139.401.8%
+DKK 639.3m		21.3%PE158x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

NOVO B

DKK 607.70

Novo Nordisk

7D

4.5%

1Y

-21.6%

EMBLA

DKK 34.00

Embla Medical hf

7D

-2.9%

1Y

13.3%

AMBU B

DKK 139.40

Ambu

7D

1.8%

1Y

21.3%

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Jan 27
Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

COLO B

DKK 831.80

Coloplast

7D

1.4%

1Y

4.3%

Coloplast A/S' (CPH:COLO B) Share Price Could Signal Some Risk

Jan 27
Coloplast A/S' (CPH:COLO B) Share Price Could Signal Some Risk

HLUN B

DKK 42.82

H. Lundbeck

7D

5.7%

1Y

22.6%

Is H. Lundbeck (CPH:HLUN B) A Risky Investment?

Jan 26
Is H. Lundbeck (CPH:HLUN B) A Risky Investment?

NNIT

DKK 95.00

NNIT

7D

1.8%

1Y

-0.9%

BAVA

DKK 194.90

Bavarian Nordic

7D

-0.5%

1Y

22.5%

GUBRA

DKK 672.00

Gubra

7D

8.4%

1Y

448.6%

PEG

DKK 0.16

Pharma Equity Group

7D

-5.8%

1Y

-51.1%

DEMANT

DKK 290.00

Demant

7D

-0.3%

1Y

-7.6%

Shareholders Should Be Pleased With Demant A/S' (CPH:DEMANT) Price

Jan 14
Shareholders Should Be Pleased With Demant A/S' (CPH:DEMANT) Price

CHEMM

DKK 500.50

ChemoMetec

7D

-1.8%

1Y

33.3%

ALK B

DKK 151.90

ALK-Abelló

7D

-1.6%

1Y

36.1%

ZEAL

DKK 728.00

Zealand Pharma

7D

-1.4%

1Y

54.2%

Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts

Dec 22
Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts

VIRO

DKK 12.80

ViroGates

7D

6.7%

1Y

62.0%

GMAB

DKK 1,394.00

Genmab

7D

-7.7%

1Y

-27.4%